Loading…
VolitionRx Limited is projected to decline to $0.6583 by 2027, a -18% move from its current price of $0.7999. VNRX is currently trading below its 50-day average (a bearish sign). Technical indicators currently lean strong sell.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 8/4/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Aug 5 | $0.7595 | $0.8002 | $0.8431 | +0.04% |
| Aug 6 | $0.7436 | $0.8006 | $0.8619 | +0.08% |
| Aug 7 | $0.7317 | $0.8009 | $0.8767 | +0.12% |
| Aug 8 | $0.7218 | $0.8012 | $0.8894 | +0.17% |
| Aug 9 | $0.7132 | $0.8016 | $0.9008 | +0.21% |
| Aug 10 | $0.7056 | $0.8019 | $0.9113 | +0.25% |
| Aug 11 | $0.6987 | $0.8022 | $0.9211 | +0.29% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $0.6987 | $0.8022 | $0.9211 | +0.29% |
| Week 2 | $0.6618 | $0.8046 | $0.9781 | +0.58% |
| Week 3 | $0.6352 | $0.8069 | $1.02 | +0.88% |
| Week 4 | $0.6139 | $0.8092 | $1.07 | +1.17% |
| Week 5 | $0.5959 | $0.8116 | $1.11 | +1.46% |
| Week 6 | $0.5803 | $0.814 | $1.14 | +1.76% |
| Week 7 | $0.5664 | $0.8163 | $1.18 | +2.05% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
VolitionRx Limited is a healthcare company that operates in the epigenetics space. It develops blood tests to help detect and monitor a range of cancers, and diseases associated with NETosis, across the United States, Europe, and Asia.
The company offers Nu.Q Vet, a cancer screening test for dogs and other animals; Nu.Q Nets, which detects diseases associated with NETosis such as sepsis; Nu.Q Discover, a solution to profiling nucleosomes; Nu.Q Cancer for predicting treatment response and monitoring treatment progression; and Capture-PCR and Capture-Seq, which isolate and capture circulating tumor-derived DNA from plasma samples for early cancer detection.
VolitionRx Limited is headquartered in Henderson, Nevada.
VolitionRx Limited trades under the symbol VNRX and currently has a price of $0.7181. Its market capitalization is $8.65M and it is ranked No.
The near-term price outlook is shown by the 2026 forecast, which lists a min price of $0.7181, an average price of $0.7181, and a max of $1.04, with a 0% ROI and a NEUTRAL sentiment.
Longer-term forecasts indicate higher potential in later years, with 2031 posting an average of $0.9163 (ROI 27.6, sentiment BULLISH), 2040 at an average of $1.02 (ROI 42.1, sentiment BULLISH), and 2050 at an average of $2.35 (ROI 227.4, sentiment BULLISH).
A major floor 69.2% below — a decisive break under it would weaken the trend.
The nearest floor, 10.0% below — buyers have tended to step in here.
The nearest ceiling, 78.8% above — a clean break opens room to run.
A major ceiling 400.1% above — clearing it would confirm fresh momentum.
Key VNRX support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of VNRX market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $0.804 | Sell | $0.8144 | Sell |
| MA 10 | $0.938 | Sell | $0.9141 | Sell |
| MA 20 | $1.11 | Sell | $1.07 | Sell |
| MA 50 | $1.55 | Sell | $1.53 | Sell |
| MA 100 | $2.37 | Sell | $2.45 | Sell |
| MA 200 | $4.23 | Sell | $4.37 | Sell |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 22.44 | Buy |
| Stoch RSI (14) | 3.59 | Buy |
| CCI (20) | -148.96 | Sell |
| Williams %R (14) | -100.00 | Info |
| MACD (12,26,9) | -0.02 | Sell |
| ROC (12) | -38.98 | Sell |
| Bollinger %B (20,2) | 0.04 | Neutral |
| Stochastic %K (14) | 0.00 | Buy |
| TRIX (15) | -1.85 | Sell |
| Awesome (5,34) | -0.40 | Sell |
| Ultimate (7,14,28) | 16.51 | Buy |
| Momentum (10) | -0.38 | Sell |
| Aroon Osc (25) | -92.00 | Sell |
| Hull MA (9) | 0.71 | Buy |
| ADX (14) | 39.78 | Sell |
| ATR (14) | 0.06 | Info |
The 30-day technical picture is NEUTRAL, with RSI14 at 20.
The stock’s trend indicators show a 50-day simple moving average of $1.55 and a 200-day simple moving average of $4.23.
Support sits at $0.72 and resistance at $1.43, with a 30-day trading range between $0.509 and $1.01.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $0.72 | $0.7999 | $1.16 | 0% | Neutral | |
| $0.4817 | $0.6583 | $0.9715 | -18% | Bearish | |
| $0.4709 | $0.6833 | $1.07 | -15% | Neutral | |
| $0.4553 | $0.6951 | $1.15 | -13% | Neutral | |
| $0.4785 | $0.7649 | $1.31 | -4% | Neutral | |
| $0.6109 | $1.02 | $1.81 | +27% | Bullish | |
| $0.5438 | $0.9453 | $1.73 | +18% | Neutral | |
| $0.4912 | $0.888 | $1.67 | +11% | Neutral | |
| $0.5017 | $0.9423 | $1.82 | +18% | Neutral | |
| $0.3901 | $0.7605 | $1.50 | -5% | Neutral | |
| $0.5105 | $1.13 | $2.46 | +42% | Bullish | |
| $1.18 | $2.62 | $6.03 | +228% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| August 2026 | $0.72 | $0.7999 | $1.02 | +0.00% |
| September 2026 | $0.6696 | $0.8129 | $1.03 | +1.62% |
| October 2026 | $0.6751 | $0.8307 | $1.07 | +2.20% |
| November 2026 | $0.7093 | $0.8826 | $1.16 | +6.24% |
| December 2026 | $0.6911 | $0.8688 | $1.16 | -1.57% |
Click any year to see its month-by-month VNRX forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
In 2026, VNRX is projected to trade between $0.72 and $1.16, averaging $0.7999 — a potential gain of 0% from today's $0.7999. A consolidation phase looks the most probable path here.
VolitionRx Limited's 2027 outlook centres on $0.6583, within a $0.4817 to $0.9715 range. That is -18% versus the projected 2026 average. That marks a -18% change versus current levels. A cyclical pullback looks likely — prices rarely move in a straight line.
By 2028, VNRX could reach as high as $1.07, with a base case around $0.6833 and support toward $0.4709 — roughly -15% from $0.7999. A consolidation phase looks the most probable path here.
Expect VNRX to range from $0.4553 to $1.15 through 2029. The $0.6951 average target implies a -13% move from current prices. That is up +2% on the projected 2028 average. Price action looks broadly range-bound.
The VNRX price prediction for 2030 points to an average of $0.7649 (low $0.4785, high $1.31) — a potential decline of -4% on today's $0.7999. A consolidation phase looks the most probable path here.
In 2031, VNRX is projected to trade between $0.6109 and $1.81, averaging $1.02 — a potential gain of +27% from today's $0.7999. That is up +33% on the projected 2030 average. Momentum favours further upside here.
VolitionRx Limited's 2032 outlook centres on $0.9453, within a $0.5438 to $1.73 range. That is -7% versus the projected 2031 average. That marks a +18% change versus current levels. A consolidation phase looks the most probable path here.
By 2033, VNRX could reach as high as $1.67, with a base case around $0.888 and support toward $0.4912 — roughly +11% from $0.7999. Price action looks broadly range-bound.
Expect VNRX to range from $0.5017 to $1.82 through 2034. The $0.9423 average target implies a +18% move from current prices. That is up +6% on the projected 2033 average. A consolidation phase looks the most probable path here.
The VNRX price prediction for 2035 points to an average of $0.7605 (low $0.3901, high $1.50) — a potential decline of -5% on today's $0.7999. Price action looks broadly range-bound.
In 2040, VNRX is projected to trade between $0.5105 and $2.46, averaging $1.13 — a potential gain of +42% from today's $0.7999. That is up +49% on the projected 2035 average. Buyers look set to stay in control over this stretch.
VolitionRx Limited's 2050 outlook centres on $2.62, within a $1.18 to $6.03 range. That is up +131% on the projected 2040 average. That marks a +228% change versus current levels. Momentum favours further upside here.
Investing $1,000 in VNRX today (≈ 1,250.15627 VNRX) could be worth
$3,278.19
+$2,278.19 (+228%) by 2050 · US Dollar
Based on the average projected VNRX price of $2.62 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in VNRXwould be worth at today's price.
$1,000 invested in VNRX on Jul 31, 2025 (≈ 78.124999 VNRX) would be worth
$62.49
-$937.51 (-93.8%) today · 0.06× · US Dollar
Based on a VNRX entry price of $12.8 vs. today's $0.7999.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $1 | $799.9 | -20.0% |
| 1 month ago | $1.36 | $588.16 | -41.2% |
| 3 months ago | $2.43 | $329.18 | -67.1% |
| 6 months ago | $5.2 | $153.83 | -84.6% |
| 1 year ago | $12.8 | $62.49 | -93.8% |
| All time (5.0y) ago | $64 | $12.5 | -98.8% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our VNRX forecast.
Our base-case forecast reaches $1.60 around 2050.
Implied market cap at $1.60: $19.27M
The multi-year forecast begins with 2026, showing min $0.7181, avg $0.7181, max $1.04 and ROI 0 with a NEUTRAL sentiment. In 2027 through 2029, the average price trends lower to around $0.59–$0.62 with negative ROI, specifically -17.8% in 2027, -14.5% in 2028, and -13.2% in 2029, while sentiment remains NEUTRAL.
In 2030 the forecast shows min $0.4297, avg $0.687, max $1.18 with ROI -4.3 and neutral sentiment. The next year, 2031, improves to min $0.549, avg $0.9163, max $1.63 with ROI 27.6 and a BULLISH outlook.
The forecast in 2040 projects min $0.4594, avg $1.02, max $2.22 with ROI 42.1 and a BULLISH sentiment. By 2050, the model envisions min $1.06, avg $2.35, max $5.41 with ROI 227.4 and a BULLISH tone. These figures illustrate a wide range of potential outcomes, reflecting uncertainty and the estimates nature of the projections.
Tap a question to reveal the answer.
2030: min $0.4297, avg $0.687, max $1.18; ROI -4.3; sentiment NEUTRAL.
Near term shows NEUTRAL sentiment with 2026 having avg $0.7181 and 0% ROI, then 2027–2029 with negative ROI (-17.8%, -14.5%, -13.2%) before a bullish turn in 2031 (avg $0.9163, ROI 27.6). Overall outcomes are uncertain and depend on future developments; these figures are not guarantees.
Yes. The forecast shows a max of $2.22 in 2040 and $5.41 in 2050, so reaching $2.00 appears possible by 2040 based on the provided projections.
Current price is $0.7181 and market cap is $8.65M.
RSI (14) is 20 with NEUTRAL sentiment. The SMA(50) is $1.55 and the SMA(200) is $4.23. Support is at $0.72 and resistance at $1.43, with a 30-day range from $0.509 to $1.01.
VolitionRx Limited Community Discussion
0Share your VolitionRx Limited price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.